Available Clinical Trials

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724).
E-mail: askrpci@roswellpark.org

(COG AALL0932) Treatment of Patients with Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-lineage Lymphoblastic Lymphoma (B-LLy)
A Phase I Study of Dovitinib (TKI258) in Combination with Gemcitabine and Capecitabine in Advanced Solid Tumors, Pancreatic and Biliary Cancers
(COG ACCL1131) A Phase III Open-Label Trial of Caspofungin vs. Azole Prophylaxis for Patients at High-Risk for Invasive Fungal Infections (IFI) Following Allogenetic Hematopoietic Cell Transplantation (HCT)
(COG AALL08B1) Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
(RTOG 1005) A Phase III Trial of Accelerated Whole Breast Irradiation with Hypofractionation Plus Concurrent Boost Versus Standard Whole Breast Irradiation Plus Sequential Boost for Early-Stage Breast Cancer
(SWOG S1007) A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer with Recurrence Score (RS) of 25 or less
(COG ACNS0831) Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 Years
(BMT CTN 1202) Prospective Multi-Center Cohort for the Evaluation of Biomarkers Predicting Risk of Complications and Mortality Following Allogeneic HCT
(CALGB 10701) A Phase II Study Of Dasatinib (Sprycel) (IND #73969, NSC #732517) As Primary Therapy Followed by Transplantation For Adults >/= 50 Years With Newly Diagnosed PH+ Acute Lymphoblastic Leukemia by CALGB, ECOG, and SWOG
A Prospective Randomized Multicenter Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients (PHACS)
Plasma Mitochondrial DAMPs in Patients Receiving Chemotherapy or Allogenetic Hematopoietic Stem Cell Transplantation
Pilot: Impact of High-Dose, Single Fraction Radiation on Immunogenicity of Sipuleucel-T in Metastatic Castration Recurrent Prostate Cancer Patients
The High-Dose Aldesleukin (IL-2) SELECT Trial: A Prospective Tissue Collection Protocol to Investigate Predictive Models of Response to High-Dose IL-2 Treatment in Patients with Advanced Melanoma
Using Social Network Analysis to Study Cancer Screening Behaviors Among Adults in Western New York
(OPT-80-302) DEFLECT-1: A Phase 3b Multi-Center, Double-Blind, Randomized, Placebo Controlled Study to Demonstrate the Safety and Efficacy of Fidaxomicin for Prophylaxis Against CLostridium difficilE-Associated Diarrhea in Individuals Undergoing H...
A Phase I Study of the P13-Kinase Inhibitor BKM120 in Combination with Docetaxel in Patients with Advanced Solid Tumors
(COG AAML05P1) Killer Immunoglobulin-Like Receptor (KIR) Incompatible Unrelated Donor Hematopoietic Stem Cell Transplantation (SCT) for AML with Monosomy 7,-5/5q-, High FLT3-ITD AR, or Refractory and Relapsed Acute Myelogenous Leukemia (AML) in Ch...
A Phase I Clinical Trial of Oral Calcitriol with Fixed Dose of Cisplatin and Gemcitabine in Patients with Advanced Solid Tumors
Intensity Modulated Radiation Therapy for Anal Cancer: Dosimetric Comparison, Acute Toxicity Profile, and Quality of Life Assessment
(CALGB 90203) A Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy Versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer -
A Phase II Randomized Study of Stereotactic Body Radiation Therapy (SBRT) Regimes for Medically Inoperable Patients with Node Negative, Peripheral Non- Small Cell Lung Cancer
(COG ALTE05N1) Umbrella Long-Term Follow-Up Protocol
KIR Genotyping for Unrelated Donor (URD) Selection Prior to Hematopoietic Cell Transplantation (HCT) for AML: Selecting a Favorable KIR Donor
MM-111-13-02-04) Randomized, Open Label, Phase 2 Study of MM-111 and Paclitaxel With or Without Trastuzumab in Patients with `"Traditional" and "Non-Traditional" HER2 Expressing Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction an...
(NCCTG N07C4) A Randomized Phase II Trial Evaluating Two Non-Pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-Wake Disturbances
(COG AHEP0731) Treatment of Children with All Stages of Hepatoblastoma
(COG AEWS1031) A Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-Metastatic Ewing Sarcoma
An Open Label Phase 1B Dose-Finding Study of TRC105 in Combination with Capecitabine for Progressive or Recurrent Metastatic Breast Cancer
(CLR 10-23) A Phase I Pharmacokinetic and Safety Study of Paclitaxel Injection Concentrate for Nano-Dispersion (PICN) Alone and in Combination with Carboplatin in Subjects with Advanced Solid Malignancies
A Correlative Study of Lung Cancer Treatment Response
Phase II Study of Cabozantinib in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Who Progressed on First-Line VEGFR-Targeted Therapy
Genetic Signature for Progression of Barrett's Esophagus to Esophageal Adenocarcinoma. A Pilot Study
(RTOG 1216) Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered with Concurrent Cisplatin versus Docetaxel versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck
(SWOG S1216) A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 With Androgen Deprivation Therapy + Bicalutamide in Patients With Newly Diagnosed Metastatic Hormone Sensitive Prostate Cancer
A Phase I/II Study of the HDAC Inhibitor LBH589 in Combination with the mTOR Inhibitor Everolimus (RAD001) in Metastatic Renal Cell Carcinoma
Easing the transition to Post-Treatment Status for Breast Cancer Patients
A Pilot Study of Broccoli Sprout Extract in Patients with Invasive Breast Cancer
Pilot Study of Oral Calcitriol in Patients at High Risk for Lung Cancer
(A051103) A Phase I Study Of RITUXIMAB, LENALIDOMIDE, And IBRUTINIB In Previously Untreated Follicular Lymphoma
(CALGB 140503) A Phase III Randomized Trial of Lobectomy Versus Sublobar Resection for Small (< 2 cm) Peripheral Non-Small Cell Lung Cancer
Assessment of Tumor Cell Viability and Various Biomarkers from De-Identified Bladder Washing Samples Obtained From Patients with Bladder Carcinoma
The National Marrow Donor Program Research Database for Allogeneic Unrelated Hematopoietic Stem Cell Transplantation and Marrow Toxic Injuries
(CALGB 140202) The CALGB Lung Cancer Tissue Bank
Collection of Blood from Healthy Donors and Patients with Non-Hodgkin's Lymphoma to Study the Immunological Activity of Peripheral Blood Mononuclear Cells (PBMC) and Human Serum
Exploring Current Smokers' Interest in Using Smokeless Tobacco Products Smokeless Tobacco Substitution for Cigarettes
(GDC4628g) A Phase Ib, Open-Label, Dose-Escalation Study of the Safety and Pharmacology of P13-Kinase Inhibitor GDC-0941 in Combination with either Paclitaxel and Carboplatin (With or Without Bevacizumab) or Pemetrexed, Cisplatin, and Bevacizumab...
Patient Reported Symptoms in Ovarian Cancer (Precision)
A Phase I/II Study of High Dose Interleukin 2, Aldesleukin, in Combination with the Histone Deacetylase Inhibitor Entinostat in Patients with Metastatic Renal Cell Carcinoma -
Evaluation of Smoker Reactions to Novel Tobacco Products
Multicenter Selective Lymphadenectomy for Melanoma Trial II: A Phase III Multicenter Randomized Trial of Sentinel Lymphadenectomy and Complete Lymph Node Dissection Versus Sentinel Lymphadenectomy Alone in Cutaneous Melanoma Patients with Molecul...
Phase I Study of LBH589, A Novel Oral Deacetylase Inhibitor in Patients with Recurrent or Refractory Hodgkin or Non-Hodgkin's Lymphoma
(COG ANBL0032) Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue
A Pilot Pre-Cystectomy Trial of Broccoli Extract in Patients with Locally Advanced Bladder Cancer
A Phase I Study of Oral Arsenic Trioxide with or without Ascorbic Acid in Adults with Myelofibrosis
A Phase 1b/2a, Open-Label, Non-Randomized Study of Birinapant in Combination with 5-azacitidine in Subjects with Myelodysplastic Syndrome who are Naive, Refractory or have Relapsed to 5-azacitidine Therapy
Pilot Study to Analyze a Novel Mechanism Underlying Response to Tamoxifen Therapy in Breast Cancer Patients
Brody Belt
A Phase 1b Dose Escalation Study of Vantictumab (OMP-18R5) in Combination with Docetaxel in Patients with Previously Treated Recurrent or Advanced Non-Small Cell Lung Cancer
(BAY 1000394/14858) Phase Ib/II Study of BAY 1000394 in Combination with Cisplatin/Etoposide or Carboplatin/Etoposide as First-Line Therapy in Subjects with Extensive Disease Small Cell Lung Cancer
Correlation of Deuterated Phenanthrene Metabolism with Bronchoepitheial Dysplasia and Metaplasia in Smokers at High Risk for Lung Cancer
FGFR1 Amplification as A Predictor of Efficacy in A Biomarker-Driven Phase II Study of BIBF 1120 in Advanced Squamous Cell Lung Cancer Patients Who Have Failed Up to Two Prior Chemotherapeutic Regimens
Examining Quality of Life Among Long-Term Survivors of Childhood Cancer
(NWU09-4-03) Phase I Multiple Dose Study of 12-Week Treatment by Selenium (Se-Methyl-L-Cysteine(MSC) and Selenium (L SeMet) in Adult Males
A Randomized Phase II Study of Oral Sapacitabine in Elderly Patients with Acute Myeloid Leukemia Previously Untreated or in First Relapse, or Previously Treated Myelodysplastic Syndrome
A Phase II Study of Single Agent Topoisomerase-I Inhibitor Polymer Conjugate, Etirinotecan Pegol (NKTR-102), in Patients with Relapsed Small Cell Lung Cancer
(BMT CTN 0601) Unrelated Donor Reduced Intensity Bone Marrow Transplant for Children with Severe Sickle Cell Disease
(COG ACCL0934) A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Randomized Placebo-Controlled, Double-Blind Study Of Cholecalciferol Replacement in Patients on Expectant Management for Localized Prostate Cancer
(COG AREN0534) Treatment for Patients with Bilateral, Multicentric, or Bilaterally-Predisposed Unilateral Wilms Tumor
(COG ACNS0821) Temozolomide with Irinotecan Versus Temozolomide, Irinotecan Plus Bevacizumab (NSC# 704865, BB-IND# 7921) for Recurrent/Refractory Medulloblastoma/CNS PNET of Childhood, A COG Randomized Phase II Screening Trial
Evaluation & Quality Assurance of the New York State Smokers' Quitline
Phase 1 Study of Safety, Tolerability and Immunological Effects of SVN53-67/M57-KLH (012410-2) in Patients with Survivin-Positive Malignant Gliomas
Lung Bronchoscopy Research Samples & Database
Leukocyte Apheresis for Research
Women's Health After Breast Cancer Study
(COG ALTE03N1) Key Adverse Events After Childhood Cancer
(BAY 1000394/14484) An Open-Label, Phase I, Dose-Escalation Study to Characterize the Safety,Tolerability, Pharmacokinetics, and Maximum Tolerated Dose of BAY 1000394 Given in a 3 Days on / 4 Days off Schedule in Subjects with Advanced Malignancies
A Pilot Study of Interstitial Photodynamic Therapy for Locally Advanced Squamous Cell Carcinoma of the Oropharynx and Oral Cavity
A Phase I/II Study of Oral Calcitriol in Combination with Ketoconazole in Androgen Independent Prostate Cancer
(FOXFIRE Global STX0112) Assessment of Overall Survival of FOLFOX6m Plus SIR-Spheres Microspheres Versus FOLFOX6m Alone as First-Line Treatment in Patients with Non-Resectable Liver Metastases from Primary Colorectal Carcinoma in a Randomized Clin...
A Phase I Study of Targeted Lung Chemotherapy in the Treatment of Metastatic Tumors
Phase I Trial of Cytarabine and Lenalidomide in Relapsed or Refractory Acute Myeloid Leukemia Patients
(COG ACNS0334) A Phase III Randomized Trial for the Treatment of Newly Diagnosed Supratentorial PNET and High Risk Medulloblastoma in Children < 36 Months Old with Intensive Induction Chemotherapy with Methotrexate Followed by Consolidation with S...
Ofatumumab (O) in Combination With Chemotherapy: Hyper-Fractionated Cyclophosphamide, Doxorubicin, Vincristine and Dexamethasone (O-HyperCVAD) Alternating With Ofatumumab High-Dose Cytarabine and Methotrexate (O-MA) for Patients With Newly Diagn...
Randomized Phase II Study of Epigenetic Priming Using Decitabine with Induction Chemotherapy in Patients with Acute Myelogenous Leukemia (AML)
(COG AAML08B1) Biology Study of Transient Myeloproliferative Disorder (TMD) in Children with Down Syndrome (DS)
(RTOG 0534) A Phase III Trial Of Short Term Androgen Deprivation With Pelvic Lymph Node Or Prostate Bed Only Radiotherapy (Spport) In Prostate Cancer Patients With A Rising PSA After Radical Prostatectomy
(COG ALTE07C1) Neuropsychological, Social, Emotional and Behavioral Outcomes in Children with Cancer
Pralatrexate in Combination with Oxaliplatin in Advanced Esophagogastric Cancer: A Phase II Trial with Predictive Molecular Correlates
(A031203) Randomized Phase II Study Comparing Cabozantinib (NSC #761968 and IND #116059) with Commercially Supplied Sunitinib in Patients with Previously Untreated Locally Advanced or Metastatic Renal Cell Carcinoma
A Phase II Study of the Combination of Aflibercept (VEGF-Trap) plus Modified FOLFOX 6 in Patients with Previously Untreated Metastatic Colorectal Cancer
Predictive Markers of Response in a Phase II Trial of Axitinib in Advanced Melanoma
A Phase 2, Randomized, Multicenter Study of PEGPH20 (PEGylated Recombinant Human Hyaluronidase) Combined with nab-Paclitaxel Plus Gemcitabine Compared With nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Previously Untreated Pancreatic C...
A Phase 1 Study of the Safety and Pharmacokinetics of Escalating Doses of AGS-22M6E Given as Monotherapy Followed By Expansion Cohorts in Subjects with Malignant Solid Tumors that Express Nectin-4
A Phase I Trial of a Recombinant Human hsp110-gp100 Chaperone Complex Vaccine for Advanced Stage IIIB/C or IV Melanoma
Immunologic Impact of Stereotactic Body Radiation Therapy (SBRT) in Renal Cell Carcinoma
(AGS-16C3F-12-2) A Phase I, Open-Label, Multi-Center Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects with Renal Cell Carcinoma of Clear Cell or Papillary Histology
A Randomized Phase III Study Comparing Conventional Dose Treatment Using a Combination of Lenalidomide, Bortezomib and Dexamethasone (RVD) to High-Dose Treatment with Peripheral Stem Cell Transplant in the Initial Management of Myeloma in Patients...
(BMT CTN Protocol 0901) A Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia
(COG AAML1031) A Phase III Randomized Trial for Patients with de novo AML Using Bortezomib and Sorafenib (IND#114480; NSC#681239, NSC#724772) for Patients with High Allelic Ratio FLT3/ITD
A Phase 1B/2 Study to Evaluate the Safety and Efficacy of PF-04449913, an Oral Hedgehog Inhibitor, in Combination with Intensive Chemotherapy, Low Dose Ara-C, or Decitibine in Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Synd...
(R1400-ST-1113) Phase I Study of REGN1400 in Combination with Erlotinib or Cetuximab Administered in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) or Head and Neck Cancer (SCCHN)
A Randomized, Open-Label, Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects with Biochemical-Recurrent-Only Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, or Fallopian Tube Cancer Following Complete Remission wi...
A Phase I Study of the mTOR Inhibitor Temsirolimus in Combination with the HDAC Inhibitor Vorinostat in Patients with Metastatic Prostate Cancer
(CALGB 20202) Assessment of Novel Molecular Markers in Acute Myeloid Leukemia
The Effect of Bortezomib on Antibody Titers Against Common Viral and Vaccine Antigens
Molecular Mechanisms Involved in Cancer Predisposition
(GOG 3003) A Randomized, Double-Blind, Placebo-Controlled Phase II Study of VTX-2337 (IND #78,416) in Combination with Pegylated Liposomal Doxorubicin (PLD) in Patients with Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Per...
Multicenter Phase 1b/2 Study of Tivozanib in Patients with Advanced Inoperable Hepatocellular Carcinoma
A Randomized, Open-Label, Multicenter, Phase II Trial Evaluating The Safety And Activity of DCDT2980S in Combination with Rituximab or DCDS4501A in Combination with Rituximab in Patients with Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
A Phase 1 Study of DEC205mAb-NY-ESO-1 Fusion Protein (CDX-1401) Given with Adjuvant PolyICLC in Conjunction with 5-Aza-2'Deoxycytidine (Decitabine) in Patients with MDS or Low Blast Count AML
A Pilot Study Evaluating NFAT, NFkB and, ERK 1/2 Nuclear Translocation as a Predictive Marker for Acute Graft-versus-Host Disease
(COG ANHL04B1) Rare and Cutaneous Non-Hodgkin Lymphoma Registry
(GOG 0273) Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal or Fallopian Tube Cancer
(COG AALL1131) A Phase III Randomized Trial for Newly Diagnosed High Risk B-Precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum
(NSABP B-47) A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphomide or Four Cycles of Doxorubicin Plus Cyclophosphomide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trast...
Phase I Dose-Finding Study of Eltrombopag Following High Dose Cytarabine and Mitoxantrone in Relapsed/Refractory Patients with Acute Myeloid Leukemia
(COG ACCL0933) A Randomized Open-Label Trial of Caspofungin Versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
N1048 PROSPECT**) A Phase II/III Trial of Neoadjuvant FOLFOX with Selective Use of Combined Modality Chemoradiaiton Versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection...
(COG ANHL1131) Intergroup Trial for Children or Adolescents with B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients
A Phase 3, Multicenter, Randomized Study to Evaluate the Substitution of MARQIBO (Vincristine Sulfate Liposomes Injection, VSLI) for Standard Vincristine Sulfate Injection (VSI) in the Induction, Intensification, and Maintenance Phases of Combinat...
A Pilot Study of the Flaxseed Effects on Hormones and Lignans: Role of Race, Genes, and Gut Microbiome
(XL184-306) A Phase 3, Randomized, Double-Blind, Controlled Trial of Cabozantinib (XL184) vs. Mitoxantrone Plus Prednisone in Men with Previously Treated Symptomatic Castration-Resistant Prostate Cancer
(GOG 0261) A Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Ifosfamide Plus Paclitaxel in Chemotherapy -Naive Patients With Newly Diagnosed Stage I-IV, Persistent or Recurrent Carcinosarcoma (Mixed Mesodermal Tumors) of the Uteru...
A Phase 1 and Pharmacologic Study of MM-151 in Patients with Refractory Advanced Solid Tumors
A Phase II Trial of Reduced Intensity Allogenenic Stem Cell Transplantation With Fludarabine, Melphalan and low Dose Total Body Irradiation
A Pilot Study of Feasibility of Performing Intravital Microscopy in Melanoma Patients
PNH Registry
(CALGB 90601) A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin and Bevacizumab to Gemcitabine, Cisplatin and Placebo in Patients with Advanced Transitional Cell Carcinoma
(RDCRN-6503) Targeted Therapy of Bronchiolitis Obliterans Syndrome (BOS)
Evaluation of Pre-Operative Nutritional Risk as a Predictor of Post-Operative Outcome in Patients Undergoing Robot-Assisted Radical Cystectomy
A Phase 1 Clinical Trial of mTOR Inhibition With Rapamycin for Enhancing Intranodal Dendritic Cell Vaccine Induced anti-Tumor Immunity In Patients with NY-ESO-1 Expressing Solid Tumors
Influence of Advertising Claim Presentation on Beliefs and Affective Associations Related to Tobacco Products
(RDCRN 6502) A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis after Allogeneic Hematopoietic Cell Transplantation
A Phase 1 Study of Evaluate the Safety, Tolerability and Efficacy of MK-8353 (formerly SCH 900353) in Subjects with Advanced Solid Tumors (Protocol No.001) formerly P06203
(GOG 0271) A Study of the Local and Systemic Effects of Intraperitoneal Chemotherapy in the Treatment of Previously-Untreated, Invasive Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma
A Phase I, Dose Escalation, Multicenter Study of Two Subcutaneous Regimens of SG1-110, a DNA Hypomethylating Agent, in Subjects with Intermediate or High-Risk Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
(CALGB 70807) The Men's Eating and Living (MEAL) Study: A Randomized Trial of Diet to Alter Disease Progression in Prostate Cancer Patients on Active Surveillance
(COG AALL0631) A Phase III Study of Risk Directed Therapy for Infants with Acute Lymphoblastic Leukemia (ALL): Randomization of Highest Risk Infants to Intensive Chemotherapy +/- FLT3 Inhibition (CEP-701, Lestraurtinib; IND #76431; NSC #617807)
A Pilot Study of Stereotactic Body Radiation Therapy (SBRT) After TEMLA for Stage III and IV (Oligometastatic) Non-Small Cell Lung Cancer
A Randomized, Open-Label, Phase 3 Study of BMS-936558 vs. Everolimus in Subjects with Advanced or Metastatic Clear-Cell Renal Cell Carcinoma Who Have Received Prior Anti-Angiogenic Therapy
(SWOG S1117) A Randomized Phase II Study of Azacitidine in Combination with Lenalidomide (NSC-703813) vs. Azacitidine Alone vs. Azacitidine in Combination with Vorinostat (NSC-701852) for Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Mye...
(COG ACNS1022) A Phase II Randomized Trial of Lenalidomide (NSC #703813, IND #70116) in Pediatric Patients with Recurrent, Refractory or Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas
Impact of Carbonyl Reductase 3 Genotype Status on Echocardiographic Measurements of Cardiomyopathy in Breast Cancer Patients Treated with Anthracyclines
A Phase I/ II Trial of Pazopanib Alternating with Bevacizumab in Treatment-Naive Metastatic Clear Cell Renal Cell Carcinoma Patients
A Phase I Clinical Trial of mTOR Inhibition with Sirolimus for Enhancing ALVAC(2)-NY-ESO-1(M)/TRICOM Vaccine Induced Anti-Tumor Immunity in Ovarian, Fallopian Tube and Primary Peritoneal Cancer
Alternative Approaches for Nausea Control
A Phase 1 Study to Evaluate the Safety and Pharmacokinetic Profile of CBLB502 in Patients with Advanced Cancers
A Phase I Pharmacokinetic, Safety and Tolerability Study of Paclitaxel Injection Concentrate for Nano-Dispersion (PICN) Administered Weekly in Subjects with Advanced Solid Malignancies in US Population